PAR-16-116: Bioengineering Research Partnerships (U01) Department of Health and Human Services Part 1.
Untitled. Untitled. NIH: National Institute of Allergy and Infectious Diseases. AHA Institutional Research Enhancement Award (AIREA) Class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_489540,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_489540_AHA-Institutional-Research-Enhancement-Award-AIREA.jsp,docTitle=AHA Institutional Research Enhancement Award (AIREA),xWebsites=professional,dDocAuthor=stacy.ragsdale,xNextReviewDate=01/27/2016 8:46 PM,xTier1=35,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=Program description, eligibility and peer review criteria for the AHA's AHA Institutional Research Enhancement Award (AIREA.
Agreements - FAPESP and the National Institutes of Health (NIH) Collaborative Research Opportunity. This call is published at www.fapesp.br/10025 1.
Introduction The National Institutes of Health (NIH) USA and the São Paulo Research Foundation (FAPESP), Brazil have signed a MoU to encourage collaborative international research between investigators in the USA and in the State of São Paulo, Brazil. Under the referred MoU, as an action to promote such collaboration, FAPESP announces this Call for Proposals inviting researchers associated to Higher Education and Research Organizations in the State of São Paulo to submit research proposals. NOT-TW-16-001: Notice of Information: Parallel Funding Initiative for Collaborative Research Between Investigators in the USA and in the State of So Paulo, Brazil. Notice of Information: Parallel Funding Initiative for Collaborative Research Between Investigators in the USA and in the State of São Paulo, Brazil Notice Number: NOT-TW-16-001 Key DatesRelease Date: January 12, 2016 Related AnnouncementsPA-16-160PA-13-302 Purpose The National Institute of Health (NIH) and the São Paulo Research Foundation (FAPESP), Brazil, have signed a memorandum of understanding (MOU) to encourage collaborative international research between investigators in the US and in the State of São Paulo.
Instructions to Applicants 1. Grants.nih.gov. National Institute of Biomedical Imaging and Bioengineering. Cells are the building blocks of tissue, and tissues are the basic unit of function in the body.
Generally, groups of cells make and secrete their own support structures, called extra-cellular matrix. This matrix, or scaffold, does more than just support the cells; it also acts as a relay station for various signaling molecules. Thus, cells receive messages from many sources that become available from the local environment. Each signal can start a chain of responses that determine what happens to the cell. By understanding how individual cells respond to signals, interact with their environment, and organize into tissues and organisms, researchers have been able to manipulate these processes to mend damaged tissues or even create new ones. The process often begins with building a scaffold from a wide set of possible sources, from proteins to plastics. Another method to create new tissue uses an existing scaffold. NOT-OD-16-134: Revised: Projected FY 2017 Stipend Levels for Postdoctoral Trainees and Fellows on Ruth L. Kirschstein National Research Service Awards (NRSA)
Revised: Projected FY 2017 Stipend Levels for Postdoctoral Trainees and Fellows on Ruth L.
Kirschstein National Research Service Awards (NRSA) Notice Number: NOT-OD-16-134 Key DatesRelease Date: August 10, 2016. Research Training and Career Development. Skip Navigation U.S.
Department of Health & Human Services National Institutes of Health Division of Biomedical Research Workforce Contact Us Individual Fellowships RTCD Home > Program Details Ruth L. Program Purpose The purpose of the Kirschstein-NRSA senior individual fellowships is to enable experienced scientists to make major changes in the direction of their research careers or to broaden their scientific background by acquiring new research capabilities as independent investigators. Eligibility Career level. Glycosaminoglycan. Glycosaminoglycans (GAGs) or mucopolysaccharides are long unbranched polysaccharides consisting of a repeating disaccharide unit.
The repeating unit (except for keratan) consists of an amino sugar (N-acetylglucosamine or N-acetylgalactosamine) along with a uronic sugar (glucuronic acid or iduronic acid) or galactose. Glycosaminoglycans are highly polar and attract water. They are therefore useful to the body as a lubricant or as a shock absorber. Mucopolysaccharidoses are a group of metabolic disorders in which abnormal accumulations of glycosaminoglycans occur because of enzyme deficiencies. Production Glycosaminoglycans have high degrees of heterogeneity with regards to molecular mass, disaccharide construction, and sulfation due to the fact that GAG synthesis, unlike proteins or nucleic acids, is not template driven, and dynamically modulated by processing enzymes.
Laser Zentrum Hannover e.V. Laser Development Department. The Laser Development Department concentrates on the development of laser sources for a variety of applications.
The research focus areas of the LZH in the field of laser development are in designing and characterizing modern, diode-pumped solid-state and fiber lasers. In the framework of their activities, the Laser Development Department covers the complete spectrum, from basic research to industrial applications. In the field of ultrashort pulse fiber oscillators, resonator-internal pulse dynamics for energy scaling are being investigated. Innovative concepts for compact, mode-locked fiber oscillators with wavelengths around 2 µm are being developed for structuring organic solar cells. Further scaling of the pulse energy for the wavelength of 2 µm using regenerative amplifiers are also being developed. Laser Zentrum Hannover e.V. Biofabrication Group.
Fastlane.nsf. SBIR / STTR Gateway - News and Search Engine. Site:sbir.gov tissue engineering. Open Topic Search. Open Topic Search. Pancreatic cancer (adenocarcinoma pancreatis) 200x. CDRH Learn. Premarket Notification (510k) The 510(k) ProgramPresentation Printable Slides Transcript Premarket Notification 510(k) OverviewPresentation Printable Slides 510(k) Format Guidance, Including Standards Form, and Extensions/Clinical Trial Form and 510(k)Presentation Printable Slides. Search Results: bioreactor medical device. Showing 1 - 10 of about 71 for bioreactor medical device July 2015 PMA Approvals Medical Devices 2015-10-23 | www.fda.gov/... /productsandmedicalprocedures/deviceapprovalsandclearances/pmaapprovals/ucm461320.htm ... TN 38132, Approval for increasing the bioreactor used to ... Cached PDF Regulatory Science Progress Report FY 2013 - FY 2014 Regulatory Information www.fda.gov/...
RFA-HL-15-008: Bioreactors for Reparative Medicine (R43/R44) Department of Health and Human Services Part 1. Overview Information. RFA-HL-15-008: Bioreactors for Reparative Medicine (R43/R44) Cholestatic Jaundice. Pathway Home Population Covered By The Guidance This pathway provides a diagnostic imaging algorithm for patients with clinically and biochemically suspected cholestatic jaundice. Date reviewed: April 2015.